A new study published in Neurology, has shown that long-term inflammation in older patients with diabetes can also hasten their cognitive decline.
Inflammation, the body's defence mechanism against injury and infection, can also lead to the development of insulin resistance and diabetes. Research has shown that a vicious cycle ensues, with insulin resistance leading to increased inflammation.
type 2 diabetes mellitus (T2DM)
Now, a new study published in Neurology, has shown that long-term inflammation in older patients with diabetes can also hasten their cognitive decline. The study authors followed 65 patients with , evenly split in both genders and an average of 66 years old, to evaluate the relationships between inflammation, cerebral vasoregulation, and cognitive decline in T2DM. When the trial participants were evaluated at 2 years, a diminished global and regional cerebral vasoreactivity was observed, along with a decline in multiple cognitive tasks compared with their baseline activity at the beginning of the study, the authors write. Additionally, the authors noted that high levels of serum soluble intercellular and vascular adhesion molecules, higher cortisol, and higher C-reactive protein levels were associated with greater decreases in cerebral vasoreactivity and vasodilation in the T2DM group.
according to study author Vera Novak, MD, PhD, of Harvard Medical School in Boston.
Their findings led to the conclusion that inflammation may further impair cerebral vasoregulation, which in turn hastens decline in executive function and daily activities that the older diabetic population performs.
Source: ScienceDaily
"Normal blood flow regulation allows the brain to redistribute blood to areas of the brain that have increased activity while performing certain tasks. People with type 2 diabetes have impaired blood flow regulation. Our results suggest that diabetes and high blood sugar impose a chronic negative effect on cognitive and decision-making skills,"
Study Finds Obesity May Worsen Multiple Sclerosis: Genetic Analysis Points to Causal Link
November 21st 2024A new study aimed at exploring the relationship between obesity and multiple sclerosis severity using genetic data finds that higher BMI and other obesity measures were associated with increased disability progression in patients with MS.
Read More
Higher Life’s Essential 8 Scores Associated With Reduced COPD Risk
November 21st 2024Higher Life’s Essential 8 (LE8) scores, especially those reflecting lower nicotine exposure and better sleep health, are inversely associated with chronic obstructive pulmonary disease (COPD) risk, emphasizing the importance of cardiovascular health (CVH) in disease prevention.
Read More
Insurance Insights: Dr Jason Shafrin Estimates DMD Insurance Value
July 18th 2024On this episode of Managed Care Cast, we're talking with the author of a study published in the July 2024 issue of The American Journal of Managed Care® that estimates the insurance value of novel Duchenne muscular dystrophy (DMD) treatment.
Listen
Study Highlights Key RA-ILD Risk Factors, Urges Early Screening
November 20th 2024This recent study highlights key risk factors for rheumatoid arthritis–associated interstitial lung disease (RA-ILD), emphasizing the importance of early screening to improve diagnosis and patient outcomes.
Read More
New Study Finds Risk Groups, Outpatient Care Barriers in Chronic Liver Disease
November 20th 2024Patients with chronic liver disease who were unable to establish care were 85% more likely to require recurrent hospitalizations. This group included a disproportionate number of women and individuals with physical limitations affecting their health.
Read More